Online customer service
National Advisory Hotline
Add: No. 17, Tianjin North Road, Yantai Development Zone
Copyright © 2020 Yantai Huaxin Biomedical Science and Technology Co., Ltd
Huaxin Biomedical
Huaxin Biomedical
Mobile official website
Yantai Huaxin Biomedical Science and Technology Co., Ltd
— CORE BRAND —
— FOUR SECTIONS —
-
Biological skin care
Huaxin Biomedicine focuses on the innovative exploration of modern biotechnology in the field of skin beautification. Through the combination of biotechnology and polymer applications, it performs targeted deep repair of damaged cells...
More -
Medical instruments
The medical cold compresses of Huaxin Biomedicine have undergone strict raw material screening, scientific experimental research and clinical safety and efficacy verification...
More -
Health, medical and functional food
Huaxin Biomedicine takes "peptides" as the starting point and uses modern biotechnology to develop and produce apple peptides, ginseng peptides, mulberry peptides and other series of products...
More -
Disinfection products
Huaxin Biomedicine actively responds to market demand and national policy promotion, and is committed to the research and development and production of disinfection products with high efficiency, high safety and a wide range of functions...
More
— ABOUT HUAXIN
Yantai Huaxin Biomedical Science and Technology Co., Ltd is affiliatede to Huaxin Group. Huaxin Biomedical and Development Team was established In 2008. Huaxin Biomedicine was formally established in 2013 It invested more than 200 million Yuan to build various top international intelligent supporting facilities such as office buildings, expert apartment buildings, GMP standard production workshops, etc.
2008year
Huaxin Biomedical and Development Team was established In 2008
50+
Professor, PhD, senior engineer, master
20+
Published academic papers in international academic journals
30
Impact factor in international academic journals
— CORE HONOR —
R & D Center
High-quality scientific and technological resources, focusing on creating an innovative R&D platform
Core Honor —
Huaxin Biomedicine Joint R&D Research Center has a professional R&D team, including more than 50 senior R&D personnel including doctors, masters, and senior engineers. A total of more than 20 academic papers have been published in international academic journals, with an impact factor of 30...
— HUAXIN EXPERT COMMITTEE —
2020-10-13
◇ Doctoral supervisor
◇ Vice Chairman of Chinese Pharmaceutical Association, Supervisor of Chinese Pharmaceutical Association
2020-10-16
◇ Distinguished Professor of Liaoning Province
◇ Dean of School of Pharmacy, Shenyang Pharmaceutical University
◇ Doctor of Pharmacy, Josai University, Japan
2020-10-13
◇ Researcher, Institute of Engineering, Chinese Academy of Sciences
◇ PhD in Molecular and Cell Biology, Dorodo University
◇ Professor of Qingdao Agricultural University
2020-10-13
◇ Distinguished researcher of Zhejiang University
◇ PhD, University of Colorado Boulder
2020-10-16
◇ PhD, University of Pittsburgh
◇ Executive Director, Institute of Gastrointestinal Research, Sun Yat-sen University
2020-10-13
◇ Professor/Assistant Dean of Tongji University College of Student Sciences
◇ Distinguished researcher and doctoral supervisor of Affiliated Oriental Hospital
2020-09-10
◇ Doctor of Shenyang Medical University
◇ Senior engineer
◇ Member of Chinese Pharmacological Society
2020-09-10
◇ Product process formula engineer
◇ Lecturer of biological skin care product training
◇ Deputy Director, Industry Development Research Institute, Chinese Academy of Management Science
2021-06-18
◇ Professor of Changchun University of Traditional Chinese Medicine
Huaxin Bio-Zhonglianhe International & Yanxuan Aishanmei project kick-off meeting was successfully held
Han Zhihui, President of Guanghua Bosite, and his working group came to Huaxin Bio to visit and exchange
Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation
"Miss Taohui" 100 echelon elites come to Huaxin to select domestic products!
— NEWS CENTER —